drugset / Trial / NCT03503513

Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury

NCT03503513

NaSingle-groupOpen-labelPrevention

Summary

A non-randomized study evaluating the efficacy of intravesical gentamicin on the occurrence rate of urinary tract infections and bladder complications in patients after spinal cord injury (SCI), and to assess its effectiveness in promoting overall quality of life (QOL), community living, and participation.

Timeline

Start
2018-08-24
Primary completion
2023-09-08
Completion
2023-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Gentamicin Small molecule 30 ml Other